Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Insulin Delivery Devices Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Insulin Delivery Devices Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Insulin Pens
      • 1.3.3 Insulin Pumps
      • 1.3.4 Insulin Syringes
      • 1.3.5 Others
    • 1.4 Market Segment by Application
      • 1.4.1 Global Insulin Delivery Devices Market Share by Application (2019-2025)
      • 1.4.2 Patients/Homecare
      • 1.4.3 Hospitals & Clinics
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Insulin Delivery Devices Production Value 2014-2025
      • 2.1.2 Global Insulin Delivery Devices Production 2014-2025
      • 2.1.3 Global Insulin Delivery Devices Capacity 2014-2025
      • 2.1.4 Global Insulin Delivery Devices Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Insulin Delivery Devices Market Size CAGR of Key Regions
      • 2.2.2 Global Insulin Delivery Devices Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Insulin Delivery Devices Capacity by Manufacturers
      • 3.1.2 Global Insulin Delivery Devices Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Insulin Delivery Devices Revenue by Manufacturers (2014-2019)
      • 3.2.2 Insulin Delivery Devices Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Insulin Delivery Devices Market Concentration Ratio (CR5 and HHI)
    • 3.3 Insulin Delivery Devices Price by Manufacturers
    • 3.4 Key Manufacturers Insulin Delivery Devices Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Insulin Delivery Devices Market
    • 3.6 Key Manufacturers Insulin Delivery Devices Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Insulin Pens Production and Production Value (2014-2019)
      • 4.1.2 Insulin Pumps Production and Production Value (2014-2019)
      • 4.1.3 Insulin Syringes Production and Production Value (2014-2019)
      • 4.1.4 Others Production and Production Value (2014-2019)
    • 4.2 Global Insulin Delivery Devices Production Market Share by Type
    • 4.3 Global Insulin Delivery Devices Production Value Market Share by Type
    • 4.4 Insulin Delivery Devices Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Insulin Delivery Devices Consumption by Application

    6 Production by Regions

    • 6.1 Global Insulin Delivery Devices Production (History Data) by Regions 2014-2019
    • 6.2 Global Insulin Delivery Devices Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Insulin Delivery Devices Production Growth Rate 2014-2019
      • 6.3.2 United States Insulin Delivery Devices Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Insulin Delivery Devices Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Insulin Delivery Devices Production Growth Rate 2014-2019
      • 6.4.2 European Union Insulin Delivery Devices Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Insulin Delivery Devices Import & Export
    • 6.5 China
      • 6.5.1 China Insulin Delivery Devices Production Growth Rate 2014-2019
      • 6.5.2 China Insulin Delivery Devices Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Insulin Delivery Devices Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Insulin Delivery Devices Consumption by Regions

    • 7.1 Global Insulin Delivery Devices Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Insulin Delivery Devices Consumption by Type
      • 7.2.2 United States Insulin Delivery Devices Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Insulin Delivery Devices Consumption by Type
      • 7.3.2 European Union Insulin Delivery Devices Consumption by Application
    • 7.4 China
      • 7.4.1 China Insulin Delivery Devices Consumption by Type
      • 7.4.2 China Insulin Delivery Devices Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Insulin Delivery Devices Consumption by Type
      • 7.5.2 Rest of World Insulin Delivery Devices Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Novo Nordisk
      • 8.1.1 Novo Nordisk Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Insulin Delivery Devices
      • 8.1.4 Insulin Delivery Devices Product Introduction
      • 8.1.5 Novo Nordisk Recent Development
    • 8.2 Sanofi
      • 8.2.1 Sanofi Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Insulin Delivery Devices
      • 8.2.4 Insulin Delivery Devices Product Introduction
      • 8.2.5 Sanofi Recent Development
    • 8.3 BD
      • 8.3.1 BD Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Insulin Delivery Devices
      • 8.3.4 Insulin Delivery Devices Product Introduction
      • 8.3.5 BD Recent Development
    • 8.4 Eli Lilly
      • 8.4.1 Eli Lilly Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Insulin Delivery Devices
      • 8.4.4 Insulin Delivery Devices Product Introduction
      • 8.4.5 Eli Lilly Recent Development
    • 8.5 Medtronic
      • 8.5.1 Medtronic Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Insulin Delivery Devices
      • 8.5.4 Insulin Delivery Devices Product Introduction
      • 8.5.5 Medtronic Recent Development
    • 8.6 Animas
      • 8.6.1 Animas Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Insulin Delivery Devices
      • 8.6.4 Insulin Delivery Devices Product Introduction
      • 8.6.5 Animas Recent Development
    • 8.7 Beta Bionics
      • 8.7.1 Beta Bionics Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Insulin Delivery Devices
      • 8.7.4 Insulin Delivery Devices Product Introduction
      • 8.7.5 Beta Bionics Recent Development
    • 8.8 Cellnovo
      • 8.8.1 Cellnovo Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Insulin Delivery Devices
      • 8.8.4 Insulin Delivery Devices Product Introduction
      • 8.8.5 Cellnovo Recent Development
    • 8.9 Copernicus
      • 8.9.1 Copernicus Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Insulin Delivery Devices
      • 8.9.4 Insulin Delivery Devices Product Introduction
      • 8.9.5 Copernicus Recent Development
    • 8.10 Dance Biopharm
      • 8.10.1 Dance Biopharm Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Insulin Delivery Devices
      • 8.10.4 Insulin Delivery Devices Product Introduction
      • 8.10.5 Dance Biopharm Recent Development
    • 8.11 Debiotech
    • 8.12 Insulet
    • 8.13 MannKind
    • 8.14 Owen Mumford
    • 8.15 Roche
    • 8.16 SOOIL
    • 8.17 Tandem Diabetes Care
    • 8.18 Valeritas
    • 8.19 West Pharma
    • 8.20 Ypsomed

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Insulin Delivery Devices Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Insulin Delivery Devices Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Insulin Delivery Devices Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Insulin Delivery Devices Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Insulin Delivery Devices Production Forecast by Type
      • 9.7.2 Global Insulin Delivery Devices Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Insulin Delivery Devices Sales Channels
      • 10.2.2 Insulin Delivery Devices Distributors
    • 10.3 Insulin Delivery Devices Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      Insulin Delivery Devices include syringes, pens, pumps, and others. The cost of syringes and insulin pens is low, which enables users to opt for them as first choice devices. High cost of insulin pumps and insulin jet injectors poses a challenge to the growth of the market. Insulin pumps and jet injectors also require special care and maintenance, which is an additional cost burden to patients.

      In 2017, the insulin pens segment accounted for the largest share of the global insulin delivery devices market. The insulin pens segment is further divided into reusable pens and disposable pens.
      On the basis of end user, the patients/homecare segment commanded the largest share of the insulin delivery devices market in 2017, and is expected to grow at the highest CAGR during the forecast period.
      In 2017, North America accounted for the largest share of the global insulin delivery devices market. The large share of this segment can be attributed to the rising prevalence of diabetes and favorable reimbursement scenario in the U.S. and Canada, growing venture capital investments and issuance of IPOs in the U.S., and FDA approvals to increase the commercial availability of insulin delivery devices in the U.S.
      In 2019, the market size of Insulin Delivery Devices is xx million US$ and it will reach xx million US$ in 2025, growing at a CAGR of xx% from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Insulin Delivery Devices.

      This report studies the global market size of Insulin Delivery Devices, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Insulin Delivery Devices production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Novo Nordisk
      Sanofi
      BD
      Eli Lilly
      Medtronic
      Animas
      Beta Bionics
      Cellnovo
      Copernicus
      Dance Biopharm
      Debiotech
      Insulet
      MannKind
      Owen Mumford
      Roche
      SOOIL
      Tandem Diabetes Care
      Valeritas
      West Pharma
      Ypsomed

      Market Segment by Product Type
      Insulin Pens
      Insulin Pumps
      Insulin Syringes
      Others

      Market Segment by Application
      Patients/Homecare
      Hospitals & Clinics

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Insulin Delivery Devices status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Insulin Delivery Devices manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Insulin Delivery Devices are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now